Qingyang Dong

Dr. Qingyang Dong


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2024 in Materials Today Bio
Verified
Journal Article
Open access
NZNingnannan Zhang
Ningnannan Zhang
TZTianzhu Zhang
Tianzhu Zhang
JFJintang Feng
Jintang Feng
JSJian Shang
Jian Shang
BZBeibei Zhang
Beibei Zhang
CSChunyang Sun
Chunyang Sun
Atherosclerosis is the leading cause of cardiovascular disease and myocardial infarction. Precise and effective plaque targeting is a major objective for therapeutic outcomes throughout various stages of atherosclerosis. Inspired by the natural recruitment of neutrophils in atherosclerotic plaques, we fabricated a simvastatin (ST)-loaded and neutrophil membrane-cloaked nanoplatform (NNPST) for enhancing localized payload delivery and atherosclerosis management. The resulting NNPST mimicked neutrophil function and significantly decreased macrophage‐mediated phagocytosis to prolong its own circulation time in the blood. Compared to pristine nanoparticles (NPST) without a membrane coating, NNPST achieved better plaque targeting in ApoE−/− mice, as indicated by neutrophils actively recruited in atherosclerotic lesions. The higher plaque homing with NNPST was monitored by dynamic fluorescence/magnetic resonance (MR) dual-modality imaging. The results further showed that NNPST efficiently prevented atherosclerosis development mainly by suppressing local inflammatory macrophages, and the percentage of plaques in the entire aortic area was reduced to 4.75 ± 1.48 % following NNPST treatment. A biosafety assessment indicated that the biomimetic NNPST induced no noticeable toxicity in the body. This approach of neutrophil membrane-camouflaged nanoparticles offers new opportunities to various therapeutic agents for on-demand delivery in neutrophil-involved inflammatory diseases.

22 September 2023 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
PDF file
YCYang Cao
Yang Cao
DWDan Wang
Dan Wang
JWJin Wu
Jin Wu
ZYZhanxin Yao
Zhanxin Yao
SSSi Shen
Si Shen
QDQingyang Dong
Qingyang Dong
Microsatellite instability (MSI) is a hypermutator phenotype caused by DNA mismatch repair deficiency. MSI has been reported in various human cancers, particularly colorectal, gastric and endometrial cancers. MSI is a promising biomarker for cancer prognosis and immune checkpoint blockade immunotherapy. Several computational methods have been developed for MSI detection using DNA- or RNA-based approaches based on next-generation sequencing. Epigenetic mechanisms, such as DNA methylation, regulate gene expression and play critical roles in the development and progression of cancer. We here developed MSI-XGNN, a new computational framework for predicting MSI status using bulk RNA-sequencing and DNA methylation data. MSI-XGNN is an explainable deep learning model that combines a graph neural network (GNN) model to extract features from the gene-methylation probe network with a CatBoost model to classify MSI status. MSI-XGNN, which requires tumor-only samples, exhibited comparable performance with two well-known methods that require tumor-normal paired sequencing data, MSIsensor and MANTIS and better performance than several other tools. MSI-XGNN also showed good generalizability on independent validation datasets. MSI-XGNN identified six MSI markers consisting of four methylation probes (EPM2AIP1|MLH1:cg14598950, EPM2AIP1|MLH1:cg27331401, LNP1:cg05428436 and TSC22D2:cg15048832) and two genes (RPL22L1 and MSH4) constituting the optimal feature subset. All six markers were significantly associated with beneficial tumor microenvironment characteristics for immunotherapy, such as tumor mutation burden, neoantigens and immune checkpoint molecules such as programmed cell death-1 and cytotoxic T-lymphocyte antigen-4. Overall, our study provides a powerful and explainable deep learning model for predicting MSI status and identifying MSI markers that can potentially be used for clinical MSI evaluation.

22 July 2024 in Pathology - Research and Practice
Verified
Journal Article
Closed access
QWQuannian Wang
Quannian Wang
DMDanyang Meng
Danyang Meng
SSSi Shen
Si Shen
YCYang Cao
Yang Cao
PZPengcheng Zhang
Pengcheng Zhang
QDQingyang Dong
Qingyang Dong

24 April 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
DMDanyang Meng
Danyang Meng
JWJinhao Wang
Jinhao Wang
LDLianqun Du
Lianqun Du
XHXiaojun Hu
Xiaojun Hu
YLYing Liu
Ying Liu
QDQingyang Dong
Qingyang Dong
Objective: To investigate the efficacy of PD-L1 blockade in restoring humoral immune response against HBV.Methods: HBV‐persistent C57BL/6J mice were established through hydrodynamic tail vein injection of 10 µg pAAV‐HBV1.2 plasmid. Subsequently, mice treated i.p. with anti‐PD‐L1 and/or anti‐CTLA‐4 at specified time points, with dosages of 500 µg, 250 µg, and 250 µg, respectively. Additionally, 5 × 105 magnetic bead‐purified plasmacytoid dendritic cells (pDCs) were adoptively transferred i.v. into the acute mouse model followed by anti-PD-L1 treatment. Quantitative real-time PCR was employed to assess the expression levels of costimulatory and tolerogenic molecules in two dendritic cell subsets. Serum HBsAg and HBsAb were measured using ELISA. Flow cytometry was utilized to quantify T follicular helper (Tfh) cells, regulatory T cells (Treg), and germinal center (GC) B cells.Results: PD-L1 blockade markedly enhanced the differentiation of Tfh cells and GC B cells in HBV-persistent C57BL/6J mice, thereby promoting HBV clearance. Additionally, pDCs exhibited an increased capacity to induce immune tolerance, with pDCs isolated from HBV carriers inducing viral persistence. This persistence was effectively counteracted by treatment with anti-PD-L1.Conclusion: pDCs mediate the dysregulation of the humoral immune response to HBV through PD-L1 in chronic hepatitis B infection, highlighting a promising target for the management of chronic HBV.

18 October 2023 in Research Square
Verified
Preprint
Open access
PDF file
MWMeng Wang
Meng Wang
YLYing Liu
Ying Liu
HLHua Li
Hua Li
HLHui Liu
Hui Liu
XWXinxing Wang
Xinxing Wang
QDQingyang Dong
Qingyang Dong
Purpose: The increasing annual mean temperature has exacerbated the severity of heat stress (HS) which could increase cardiac burden. Paeoniflorin (PF), the primary bioactive constituent extracted from the Paeonifloraceae, exhibits robust antioxidant properties. However, its protective potential against HS-induced cardiomyocyte injury remains unclear. This study aimed to investigate the protective effects of PF on H9c2 cells subjected to HS-induced injury and elucidate the underlying mechanisms. Methods: To establish the heat stress model, H9c2 cells were exposed to HS for 2 h at 45 °C in a 5% CO2 incubator. Before HS exposure, H9c2 cells were pretreated with PF (5 µM) for 24 h. Subsequently, we assessed cell viability, oxidative stress, cardiomyocyte apoptosis, and mitochondrial function. Results: HS treatment significantly increased oxidative stress and apoptosis in H9c2 cells. However, pretreatment with PF for 24 h attenuated the HS-induced damage in H9c2 cells, protecting against thermal injury. Conclusion: Current studies have not investigated the role of PF on oxidative damage and apoptosis in vitro after HS. Our experiment demonstrated that PF ameliorates HS-induced oxidative stress and apoptosis in H9c2 cells which suggest that PF can potentially be an effective preventive medicine against heat injury to cardiomyocyte.